Abstract
Purpose
Although vitamin D is reportedly associated with various cancers, the association between vitamin D and thyroid cancer is indefinite. We aimed to investigate whether this association applies to thyroid cancer (TC).
Methods
A total of 276 Chinese Han people were recruited in a current matched case–control study. Multivariable conditional logistic regression was computed to estimate the association between plasma 25(OH)D and papillary thyroid cancer (PTC). In addition, we searched relevant studies in PubMed and Web of Science databases before December 2017 to conduct a meta-analysis.
Results
In our case–control study, plasma 25(OH)D concentration was inversely associated with PTC risk (highest tertile vs lowest tertile: adjusted OR = 0.25; 95% CI 0.10, 0.61; Ptrend = 0.003). This association was independent of body mass index and physical activity (all adjusted Pinteraction > 0.05). A total of 11 studies were included in the meta-analysis, among which ten studies have been published and one was our case–control study. Compared with 25(OH)D non-deficient group, the pooled OR of TC was 1.42 (95% CI 1.17, 1.73) in the deficient group. Similarly, blood 25(OH)D levels in patients with TC were tend to be lower than those in the controls (SMD = − 0.20, 95% CI − 0.36, − 0.03).
Conclusions
A high level of circulating 25(OH)D was associated with a decreased TC risk. This association has important significance in public health and should, therefore, be further studied.
Similar content being viewed by others
References
Malandrino P, Pellegriti G, Attard M, Violi MA, Giordano C, Sciacca L, Regalbuto C, Squatrito S, Vigneri R (2013) Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries. J Clin Endocrinol Metabol 98(4):1427–1434. https://doi.org/10.1210/jc.2012-3728
Vaccarella S, Dal Maso L, Laversanne M, Bray F, Plummer M, Franceschi S (2015) The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid 25(10):1127–1136. https://doi.org/10.1089/thy.2015.0116
Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317(13):1338–1348. https://doi.org/10.1001/jama.2017.2719
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115–132. https://doi.org/10.3322/caac.21338
Sinnott B, Ron E, Schneider AB (2010) Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev 31(5):756–773. https://doi.org/10.1210/er.2010-0003
Xhaard C, de Vathaire F, Clero E, Maillard S, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Danzon A, Velten M, Marrer E, Bailly L, Barjoan EM, Schlumberger M, Orgiazzi J, Adjadj E, Rubino C (2015) Anthropometric risk factors for differentiated thyroid cancer in young men and women from eastern france: a case–control Study. Am J Epidemiol 182(3):202–214. https://doi.org/10.1093/aje/kwv048
Hwang Y, Lee KE, Park YJ, Kim SJ, Kwon H, Park DJ, Cho B, Choi HC, Kang D, Park SK (2016) Annual average changes in adult obesity as a risk factor for papillary thyroid cancer: a large-scale case–control Study. Medicine 95(9):e2893. https://doi.org/10.1097/MD.0000000000002893
Xhaard C, Rubino C, Clero E, Maillard S, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Danzon A, Velten M, Buemi A, Bailly L, Marine Barjoan E, Schlumberger M, Orgiazzi J, Adjadj E, de Vathaire F (2014) Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study. Am J Epidemiol 180(10):1007–1017. https://doi.org/10.1093/aje/kwu220
Zamora-Ros R, Castaneda J, Rinaldi S, Cayssials V, Slimani N, Weiderpass E, Tsilidis KK, Boutron-Ruault MC, Overvad K, Eriksen AK, Tjonneland A, Kuhn T, Katzke V, Boeing H, Trichopoulou A, La Vecchia C, Kotanidou A, Palli D, Grioni S, Mattiello A, Tumino R, Sciannameo V, Lund E, Merino S, Salamanca- Fernandez E, Amiano P, Huerta JM, Barricarte A, Ericson U, Almquist M, Hennings J, Sandstrom M, Bueno-de-Mesquita HB, Peeters PH, Khaw KT, Wareham NJ, Schmidt JA, Cross AJ, Riboli E, Scalbert A, Romieu I, Agudo A, Franceschi S (2017) consumption of fish is not associated with risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition (epic) Study. J Nutr 147(7):1366–1373. https://doi.org/10.3945/jn.117.247874
Sen A, Tsilidis KK, Allen NE, Rinaldi S, Appleby PN, Almquist M, Schmidt JA, Dahm CC, Overvad K, Tjonneland A, Rostgaard-Hansen AL, Clavel-Chapelon F, Baglietto L, Boutron-Ruault MC, Kuhn T, Katze VA, Boeing H, Trichopoulou A, Tsironis C, Lagiou P, Palli D, Pala V, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HA, Peeters PH, Hjartaker A, Lund E, Weiderpass E, Quiros JR, Agudo A, Sanchez MJ, Arriola L, Gavrila D, Gurrea AB, Tosovic A, Hennings J, Sandstrom M, Romieu I, Ferrari P, Zamora-Ros R, Khaw KT, Wareham NJ, Riboli E, Gunter M, Franceschi S (2015) Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer 113(5):840–847. https://doi.org/10.1038/bjc.2015.280
Zamora-Ros R, Rinaldi S, Tsilidis KK, Weiderpass E, Boutron-Ruault MC, Rostgaard-Hansen AL, Tjonneland A, Clavel-Chapelon F, Mesrine S, Katzke VA, Kuhn T, Forster J, Boeing H, Trichopoulou A, Lagiou P, Klinaki E, Masala G, Sieri S, Ricceri F, Tumino R, Mattiello A, Peeters PH, Bueno-de-Mesquita HB, Engeset D, Skeie G, Arguelles M, Agudo A, Sanchez MJ, Chirlaque MD, Barricarte A, Chamosa S, Almquist M, Tosovic A, Hennings J, Sandstrom M, Schmidt JA, Khaw KT, Wareham NJ, Cross AJ, Slimani N, Byrnes G, Romieu I, Riboli E, Franceschi S (2016) Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer 138(1):65–73. https://doi.org/10.1002/ijc.29693
Kim D (2017) The role of vitamin D in thyroid diseases. Int J Mol Sci. https://doi.org/10.3390/ijms18091949
Muscogiuri G, Tirabassi G, Bizzaro G, Orio F, Paschou SA, Vryonidou A, Balercia G, Shoenfeld Y, Colao A (2015) Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr 69(3):291–296. https://doi.org/10.1038/ejcn.2014.265
Yu J, Mai W, Cui Y, Kong L (2016) Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis. J Endocrinol Invest 39(11):1285–1293. https://doi.org/10.1007/s40618-016-0491-z
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. https://doi.org/10.1056/NEJMra070553
Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ (2014) The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 14(5):342–357. https://doi.org/10.1038/nrc3691
Dackiw AP, Ezzat S, Huang P, Liu W, Asa SL (2004) Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer. Endocrinology 145(12):5840–5846. https://doi.org/10.1210/en.2004-0785
Clinckspoor I, Verlinden L, Overbergh L, Korch C, Bouillon R, Mathieu C, Verstuyf A, Decallonne B (2011) 1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer. J Steroid Biochem Mol Biol 124(1–2):1–9. https://doi.org/10.1016/j.jsbmb.2010.12.008
Fleet JC, DeSmet M, Johnson R, Li Y (2012) Vitamin D and cancer: a review of molecular mechanisms. Biochem J 441(1):61–76. https://doi.org/10.1042/BJ20110744
Somjen D, Grafi-Cohen M, Posner GH, Sharon O, Kraiem Z, Stern N (2013) Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1alpha-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines. J Steroid Biochem Mol Biol 136:80–82. https://doi.org/10.1016/j.jsbmb.2012.09.015
Wang F, Wang Y, Wang L, Wang X, Sun C, Xing M, Zhao W (2014) Strong association of high urinary iodine with thyroid nodule and papillary thyroid cancer. Tumour Biol 35(11):11375–11379. https://doi.org/10.1007/s13277-014-2397-8
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine S (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 96(7):1911–1930. https://doi.org/10.1210/jc.2011-0385
Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605. https://doi.org/10.1007/s10654-010-9491-z
Hu J, Dong Y, Chen X, Liu Y, Ma D, Liu X, Zheng R, Mao X, Chen T, He W (2015) Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies. Compr Psychiatry 61:78–89. https://doi.org/10.1016/j.comppsych.2015.05.001
Belardi V, Fiore E, Giustarini E, Muller I, Sabatini S, Rosellini V, Seregni E, Agresti R, Marcocci C, Vitti P, Giani C (2013) Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer? J Endocrinol Invest 36(5):321–325. https://doi.org/10.3275/8580
Choi YM, Kim WG, Kim TY, Bae SJ, Kim HK, Jang EK, Jeon MJ, Han JM, Shong YK, Kim WB (2017) Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease. Korean J Intern Med 32(1):102–108. https://doi.org/10.3904/kjim.2015.090
Roskies M, Dolev Y, Caglar D, Hier MP, Mlynarek A, Majdan A, Payne RJ (2012) Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg = Le Journal d’oto-rhino-laryngologie et de chirurgie cervico-faciale 41(3):160–163
Laney N, Meza J, Lyden E, Erickson J, Treude K, Goldner W (2010) The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients. Int J Endocrinol 2010:805716. https://doi.org/10.1155/2010/805716
Penna-Martinez M, Ramos-Lopez E, Stern J, Hinsch N, Hansmann ML, Selkinski I, Grunwald F, Vorlander C, Wahl RA, Bechstein WO, Zeuzem S, Holzer K, Badenhoop K (2009) Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid 19(6):623–628. https://doi.org/10.1089/thy.2008.0388
Jonklaas J, Danielsen M, Wang H (2013) A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. Thyroid 23(9):1079–1086. https://doi.org/10.1089/thy.2012.0548
Danilovic DL, Ferraz-de-Souza B, Fabri AW, Santana NO, Kulcsar MA, Cernea CR, Marui S, Hoff AO (2016) 25-Hydroxyvitamin D and TSH as risk factors or prognostic markers in thyroid carcinoma. PLoS One 11(10):e0164550. https://doi.org/10.1371/journal.pone.0164550
Sahin M, Ucan B, Ginis Z, Topaloglu O, Gungunes A, Bozkurt NC, Arslan MS, Unsal IO, Akkaymak ET, Demirci T, Karakose M, Caliskan M, Cakal E, Ozbek M, Delibasi T (2013) Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol 30(2):589. https://doi.org/10.1007/s12032-013-0589-5
Penna-Martinez M, Ramos-Lopez E, Stern J, Kahles H, Hinsch N, Hansmann ML, Selkinski I, Grunwald F, Vorlander C, Bechstein WO, Zeuzem S, Holzer K, Badenhoop K (2012) Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma. Thyroid 22(7):709–716. https://doi.org/10.1089/thy.2011.0330
Emami A, Nazem MR, Shekarriz R, Hedayati M (2017) Micronutrient status (calcium, zinc, vitamins D and E) in patients with medullary thyroid carcinoma: a cross-sectional study. Nutrition 41:86–89. https://doi.org/10.1016/j.nut.2017.04.004
Song Q, Wang B, Wang S, He Q, Zhang YM, Chen WH (2016) Significance of serum phosphorus, and vitamin D in papillary thyroid cancer patients in the eastern coastal China. Int J Clin Exp Pathol 9:3858
Zhao H, Li H, Huang T (2017) High urinary iodine, thyroid autoantibodies, and thyroid-stimulating hormone for papillary thyroid cancer risk. Biol Trace Elem Res. https://doi.org/10.1007/s12011-017-1209-6
Siegel RL, Miller KD, Jemal A (2017) Cancer Statistics, 2017. CA Cancer J Clin 67(1):7–30. https://doi.org/10.3322/caac.21387
Krishnan AV, Swami S, Feldman D (2010) Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol 121(1–2):343–348. https://doi.org/10.1016/j.jsbmb.2010.02.009
Park S, Oh CM, Cho H, Lee JY, Jung KW, Jun JK, Won YJ, Kong HJ, Choi KS, Lee YJ, Lee JS (2016) Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide study. BMJ 355:i5745. https://doi.org/10.1136/bmj.i5745
Wang J, Lv S, Chen G, Gao C, He J, Zhong H, Xu Y (2015) Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients 7(4):2485–2498. https://doi.org/10.3390/nu7042485
Kivity S, Agmon-Levin N, Zisappl M, Shapira Y, Nagy EV, Danko K, Szekanecz Z, Langevitz P, Shoenfeld Y (2011) Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 8(3):243–247. https://doi.org/10.1038/cmi.2010.73
Castoro C, Le Moli R, Arpi ML, Tavarelli M, Sapuppo G, Frittitta L, Squatrito S, Pellegriti G (2016) Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution. J Endocrinol Invest 39(7):779–784. https://doi.org/10.1007/s40618-016-0445-5
Zhang L, Li H, Ji QH, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y (2012) The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease. BMC Cancer 12:610. https://doi.org/10.1186/1471-2407-12-610
Zheng J, Li C, Lu W, Wang C, Ai Z (2016) Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer. Oncotarget 7(23):34918–34929. https://doi.org/10.18632/oncotarget.9201
Rinaldi S, Plummer M, Biessy C, Tsilidis KK, Ostergaard JN, Overvad K, Tjonneland A, Halkjaer J, Boutron-Ruault MC, Clavel-Chapelon F, Dossus L, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Agnoli C, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Lund E, Quiros JR, Agudo A, Molina E, Larranaga N, Navarro C, Ardanaz E, Manjer J, Almquist M, Sandstrom M, Hennings J, Khaw KT, Schmidt J, Travis RC, Byrnes G, Scalbert A, Romieu I, Gunter M, Riboli E, Franceschi S (2014) Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst 106(6):dju97. https://doi.org/10.1093/jnci/dju097
Bizzaro G, Shoenfeld Y (2015) Vitamin D and autoimmune thyroid diseases: facts and unresolved questions. Immunol Res 61(1–2):46–52. https://doi.org/10.1007/s12026-014-8579-z
Kim JR, Kim BH, Kim SM, Oh MY, Kim WJ, Jeon YK, Kim SS, Lee BJ, Kim YK, Kim IJ (2014) Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer. Thyroid 24(11):1618–1624. https://doi.org/10.1089/thy.2014.0090
Yavropoulou MP, Panagiotou G, Topouridou K, Karayannopoulou G, Koletsa T, Zarampoukas T, Goropoulos A, Chatzaki E, Yovos JG, Pazaitou-Panayiotou K (2017) Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features. J Endocrinol Invest 40(12):1327–1335. https://doi.org/10.1007/s40618-017-0700-4
Palacios C, Gonzalez L (2014) Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol 144 Pt A:138–145. https://doi.org/10.1016/j.jsbmb.2013.11.003
Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, Pierroz DD, Weber P, Hoffmann K (2014) A systematic review of vitamin D status in populations worldwide. Br J Nutr 111(1):23–45. https://doi.org/10.1017/S0007114513001840
Funding
This work was supported by National Natural Science Foundation of China (No. 81373071) and the Project for Anhui Province Academic Technology Leader Reserve Candidates’ Academic Research Activities (2017H108).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Anhui Medical University Biomedical Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Fig.
1 The funnel plots of meta-analysis for 25(OH)D levels and thyroid cancer. The 25(OH)D levels were modeled as binary variable (a) and continuous variable (b) (TIFF 921 kb)
Rights and permissions
About this article
Cite this article
Hu, MJ., Zhang, Q., Liang, L. et al. Association between vitamin D deficiency and risk of thyroid cancer: a case–control study and a meta-analysis. J Endocrinol Invest 41, 1199–1210 (2018). https://doi.org/10.1007/s40618-018-0853-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-018-0853-9